-
BINDING SITE OFFERS ANTIGENS & ANTIBODIES WITH EMPHASIS ON HUMAN COAGULATION APPLICATIONS
Jul 31, 2019, 09:48 AM by Michael CroftSAN DIEGO, CA - Jul 31, 2019 - San Diego, CA . . . . Binding Sites IMMUNOLOGICALS GROUP is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation testing applicationsFull story -
BetterPT and BlueJay Mobile Health Announce Partnership to Expand Connectivity Between Patients, Physical Therapists and Healthcare Providers
Jul 30, 2019, 10:44 AM by Michael CroftNEW YORK, NY - Jul 30, 2019 - BetterPT, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and BlueJay Mobile Health, a full-service mobile technology company transforming healthcare delivery and care team coordination through AI-powered telehealth, today announced a partnership to bridge patients, PTs and healthcare providers through the full continuum of careFull story -
OHSU to Become First Health System in Oregon to Implement Kyruus ProviderMatch®
Jul 30, 2019, 10:17 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 30, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OHSU in Portland, Oregon, a nationally distinguished research organization, will utilize the Kyruus ProviderMatch® platform to enhance patient access to providers and services across the OHSU health systemFull story -
MR Solutions receives a Third Queen’s Award for innovative PET imaging technology in pre-clinical scanners
Jul 30, 2019, 10:10 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queens Award for Enterprise in recognition of the companys innovative PET imaging technology for use in pre-clinical researchFull story -
X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome
Jul 30, 2019, 10:07 AM by Michael CroftCAMBRIDGE, MA, US - Jul 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the European Commission (EC), based on a favorable recommendation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation (ODD) to mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease caused by genetic mutations in the CXCR4 receptor geneFull story -
Trinity Cyber Secures $23 Million in Funding, Led by Intel Capital, to Redefine Cybersecurity by Proactively Disrupting Cyber Attacks
Jul 30, 2019, 09:06 AM by Michael CroftBOWIE, MD - Jul 30, 2019 - Start-up Trinity Cyber achieved a major milestone with its closure today on $23 million in funding from top institutional investors led by Intel CapitalFull story -
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform
Jul 30, 2019, 08:15 AM by Michael CroftPRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19Full story -
How PetaGene 'Nailed It' With Their PetaSuite Protect
Jul 30, 2019, 07:00 AM by Michael CroftFull storyBio-IT World | With the rapid growth of genomic data and the need for access by cross-functional teams, it is vital to ensure that this sensitive data is adequately protected and monitored. PetaGene's PetaSuite Protect ensures that protection.
-
BOC Sciences Offers Inhibitor Eribulin for Breast Cancer Research
Jul 29, 2019, 22:44 PM by Michael CroftSHIRLEY, NY, NY, UNITED STATES - Jul 30, 2019 - The world's leading chemical vendor BOC Sciences announces at its headquarter in New York to release a featuring inhibitor chemical – eribulin – for researchers who are involved with breast cancer research in the pharmaceutical industryFull story -
Novo Nordisk: Natural Language Processing On A Steady Diet Of Real-World Data
Jul 29, 2019, 14:05 PM by Michael CroftFull storyBio-IT World | Natural language processing is finding novel applications at Novo Nordisk, turning a trio of real-world data sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost.
-
Microway Appoints Lorne Wilson as COO
Jul 29, 2019, 10:33 AM by Michael CroftPLYMOUTH, MA - Jul 29, 2019 - Microway Appoints Lorne Wilson as COOExperienced IT executive to lead company operations toward continued growth Microway, a leading provider of fully integrated and validated computational clusters, servers, and workstations for AI and HPC, announces the appointment of Lorne Wilson as Chief Operating OfficerFull story -
TrialScope Taps Industry Veteran as CTO
Jul 29, 2019, 09:17 AM by Michael CroftBURLINGTON, NJ, UNITED STATES - Jul 29, 2019 - TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology OfficerFull story -
First CRISPR Study Inside The Body To Start In US
Jul 25, 2019, 13:30 PM by Michael CroftFull storySTAT | Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.
-
Chr. Hansen adopts NiceLabel technology to support mission-critical production
Jul 25, 2019, 11:59 AM by Michael CroftREDONDO BEACH, CA - Jul 25, 2019 - Chr. Hansen develops and produces cultures, enzymes, probiotics and natural colors for the food, confectionary, beverages, dietary supplements and animal feed industriesFull story -
Machine Reasoning Extends AI's Scope In Clinical Data Quality And Research
Jul 24, 2019, 13:30 PM by Michael CroftFull storyBio-IT World Contributed Commentary | Clinicians are faced with tedious data entry that can benefit by unobtrusive input verification and auto-completion. Coupling traditional data quality methods with AI makes it possible to efficiently solve issues like ensuring correct data, reporting to related systems, identifying medicine interactions, improving care processes—without changing clinical workflows.
-
Creative Biolabs Released Anti-CD20 Immunocytokine for Autoimmune Diseases
Jul 23, 2019, 03:03 AM by Michael CroftSHIRLEY, NY - Jul 23, 2019 - Over the last ten years, Creative Biolabs has made great progress in the field of recombinant antibody discovery and manufacturing, and now has been one of the best leaders and suppliers in antibody production fieldFull story -
Genedata's 'No BS AI'
Jul 22, 2019, 14:35 PM by Michael CroftFull storyBio-IT World | Genedata recently won Bio-IT World's "No BS AI" Best of Show Award during the Bio-IT World Conference & Expo for its deep learning-based solution for phenotypic imaging and corresponding workflows, Imagence.
-
Operations commence at Wasdell Group’s EU headquarters
Jul 19, 2019, 09:49 AM by Michael Croft- Jul 19, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has today announced its new state-of-the-art facility in Dundalk, Ireland has received its Manufacturers / Importation Authorisation licence (MIA) from the Health Products Regulatory Authority (HPRA)Full story -
Stimwave Appoints Regina E. Groves and Marc A. Loev, M.D., to Board of Directors and James M. Rallo as Chief Financial Officer
Jul 18, 2019, 12:32 PM by Michael CroftNEW YORK, NY, UNITED STATES - Jul 17, 2019 - Stimwave Technologies, the leading innovator of wireless medical pain relief implant bioelectric technology, has announced the appointments of Regina EFull story -
BetterPT Partners with Kno2 to Establish Interoperable Referral Network to Fill the Information Gap in Physical Therapy
Jul 18, 2019, 11:43 AM by Michael CroftNEW YORK, NY, UNITED STATES - Jul 18, 2019 - BetterPT, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients and physicians, and Kno2®, the company that provides Interoperability as a Service to everyone in healthcare, today announced plans to launch a fully interoperable referral network that bridges the gap between physician referrers and PTs, enhancing greater patient access to physical therapyFull story